Stockreport

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform [Read more]